1 study found for:    12639709 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors
Condition: Neoplasms
Interventions: Drug: Bevacizumab;   Drug: BAY 43-9006

Indicates status has not been verified in more than two years